M e d i c i n e A v e n u e 1 Client: Pfizer. Agency: Dorritie & Lyons. AD.Thomas Velardi Copy: Carol Shepko (1984). 2 Client: Roche. Agency: McAdams. AD: Carl Opalek. Copy: John Avery. 3 Client: Glaxo Roche. Agency: McAdams. CD: Walter Scott. AD: Chris Leila. Copy: Kevin McShane. 1 MIXEDANGINA Clinical Clues to MIXEDANGINA The work was proceeding on schedule but now it's needed awees earlier One cf the problems this new schedule creates is emotional stress And. for this conscientious worker, emotional stress brings with it the pai aoi angina So. although his myocardial oxygen demand has not increased, he's having under emotional stress at varying levels of exercise cat rest, or even during sleep upon exposure to cold diurnally, typically in the morning PROCARDIA® (nifedipine) is a primary, therapy for the patient with MIXED ANGINA It prevents vasoconstriction in both largecoronary arter ies and coronary arterioles to maintain myocardial blood flow and oxygen supply At the same time PROCARDIAdilates peripheral arteries to reduce afterload and myocardial oxygen demand As a result. PROCARDIA can significantly reduce your patient's angina attack rate and need fot nitroglycerin; event ischemia and pain occur unpredictable 84
RkJQdWJsaXNoZXIy NDMwNDAx